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Abstract
The World Health Organization (WHO) issued a recommendation (Technical Consultation: Paris 2006, Luxembourg 2007) that salt con-
sumption, as a risk factor for hypertension, atherosclerosis, myocardial infarction, stroke, and select cancers, should be restricted. The
European Commission looked to adhere to this recommendation by creating the High Level Group on Nutrition and Physical Activity.
According to WHO
recommendations, a daily allowance of 5 g NaCl (i.e., 2 g Na) for individual salt consumption should not be exceeded. At present, mean
individual salt consumption in Poland totals 13.5 g, of which salt used in household constitutes 8.8 g. In some regions of Poland, this
number reaches upwards of 15.0 g/person. The Position Paper on Initiatives Aimed at Decreasing Salt Consumption in Poland, developed
by an expert group at the National Food and Nutrition Institute, set the course for intervention, including changing recipes for mass-
produced food products and large-scale catering, improving oversight by food control agencies, and continuing legislative changes. These
interventions should also include education directed towards consumers, food producers, public health professionals, healthcare workers,
and media representatives. The Position Paper of the Polish Hypertension Society also sets the course for promoting restricted salt con-
sumption and controlling hypertension on a population level. However, household salt is the main carrier of iodine in the Polish model of
iodine prophylaxis. Thus, any interventions also require synchronized action with the Polish Council for Control of Iodine Deficiency
Disorders. Current efforts aimed at preventing iodine-deficiency look to increase consumption of other iodine-rich products (e.g., milk,
mineral water) with standardized levels of iodine. Once they achieve an iodine concentration of 0.1–0.2 mg, these products can easily
supplement any decrease in physiological iodine levels resulting from reduced salt consumption. Also required are wide-ranging educa-
tional campaigns which will be coordinated by the new designated WHO Collaborating Centre for Nutrition at the Chair of Endocrinolo-
gy at Jagiellonian University, Collegium Medicum in Kraków. (Pol J Endocrinol 2010; 61 (1): 135–140)
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Streszczenie
Światowa Organizacja Zdrowia (WHO, World Health Organization) wystosowała rekomendacje (Techniczne Konsultacje : Paryż 2006,
Luksemburg 2007) dotyczące konieczności ograniczenia spożycia soli jako czynnika ryzyka nadciśnienia tętniczego, miażdżycy, zawałów
serca, udarów oraz niektórych chorób nowotworowych. Wyzwanie to podjęła Komisja Europejska i utworzona przez nią Grupa Wysokie-
go Szczebla ds. Żywienia i Aktywności Fizycznej. Zgodnie z zaleceniami WHO dzienne spożyci soli nie powinno przekraczać 5 gr NaCl
(2 g sodu)/osobę. Średnie dzienne spożycie soli w Polsce wynosi 13,5 g/osobę, w tym 8,8 g soli kuchennej, a w niektórych regionach kraju
dochodzi do 15,0 g/osobę. Opracowane przez grono ekspertów Instytutu Żywności i Żywienia „Stanowisko w sprawie podjęcia inicjaty-
wy zmniejszenia spożycia soli w Polsce” określa kierunki działania obejmujące: zmiany receptur przetworów spożywczych w przemyśle
spożywczym i placówkach żywienia zbiorowego, wzmożenie nadzoru organów urzędowej kontroli żywności, kontynuacje odpowied-
nich działań legislacyjnych. Dotyczą one również działań edukacyjnych, kierowanych do konsumentów, producentów żywności, pra-
cowników ochrony zdrowia i instytucji zdrowia publicznego, oraz przedstawicieli mediów. Stanowisko Polskiego Towarzystwa Nadciś-
nienia Tętniczego podejmuje akcję promocji ograniczania spożycia soli i kontroli nadciśnienia tętniczego na poziomie populacyjnym.
Program taki wymaga synchronizacji działań z Polską Komisją ds. Kontroli Zaburzeń z Niedoboru Jodu w zakresie niezbędnych modyfi-
kacji systemu profilaktyki jodowej. Ograniczenie spożycia soli zmniejszy bowiem dzienną dawkę jodu. Aktualne modyfikacje systemu
profilaktyki jodowej idą w kierunku zwiększenia spożycia innych nośników jodu: mleka i wód mineralnych ze sprawdzoną zawartością
jodu. W obu wypadkach stężenie jodu osiąga wartość 0,1–0,2 mg jodków i nośniki te mogą uzupełnić niedobór jodu spowodowany
ograniczeniem spożycia soli. Wymaga to szerokiej akcji edukacyjnej, która jest częścią programu nowopowołanego Ośrodka Współpracu-
jącego z WHO w zakresie żywienia przy Klinice Endokrynologii UJCM w Krakowie. (Endokrynol Pol 2010; 61 (1): 135–140)
Słowa kluczowe: profilaktyka jodowa, wole, ograniczenie spożycia soli, nadciśnienie
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Introduction
After considering the harmful effects of a high dietary
salt concentration, the WHO Consultation of Experts
held in Paris in 2006 [1] and Luxembourg in 2007 [2]
recommended that daily salt consumption be limited
to 5 grams NaCl, equivalent to 2 grams Na, per person.
The High Level Group on Nutrition and Physical Acti-
vity was entrusted with seeing this recommendation
applied in practice in Poland. Activities aimed at redu-
cing salt consumption were listed as priorities for 2008.
Salt consumption in Poland, compared to other Euro-
pean countries, is exceptionally high (Table I). Excessi-
ve dietary salt consumption is a risk factor for arterial
hypertension, which may further lead to such negative
health events as stroke, myocardial infarction, cardiac
failure, osteoporosis, and certain neoplasms. Hyperten-
sion currently affects approximately nine million Poles.
Complications associated with hypertension are curren-
tly the leading causes of death among those aged
60 years and over. They are also the second leading cau-
se of death among those aged 15–59 years. In 2005, the
high cost of treating these complications in the Europe-
an Union was estimated at EUR 169 billion [3]. The Chair
and Clinic of Endocrinology at Jagiellonian University
Medical College is currently coordinating two pione-
ering programs aimed at reducing daily dietary salt con-
sumption: a multi-centre Program to Eliminate Iodine
Deficiency (financed by the Polish Ministry of Health)
[4], and a program regulating dietary salt consumption
among patients at the University Hospital in Kraków.
However, any effort aimed at lowering daily dietary salt
consumption in Poland should be far-reaching and
enacted on a large population level. It should target,
among others, food consumers and producers, health-
care and public health professionals, state-run oversi-
ght agencies, and media representatives. Such efforts
need to be further coordinated with initiatives meant
to ensure proper iodine consumption, as recommen-
ded by the WHO (Table II). In Poland, as in other Euro-
pean countries, iodine prophylaxis initiatives are cen-
tred on supplementing table salt with iodine. Such sup-
plementation is calculated based on actual salt con-
sumption [5]. Functioning since 1998, the Polish
Commission to Prevent the Effects of Iodine Deficien-
cy has instituted a mandatory iodine prophylaxis pro-
gram based on the iodization of table salt at concentra-
tions totalling 30 ± 10 mg KJ/kg [6]. This program was
found to be exceptionally effective; in just a few years
endemic goiter among school-aged children was com-
pletely eliminated [7].
As a result, restricting daily dietary salt consump-
tion requires that iodine prophylaxis interventions be
additionally modified. It is further essential that both
programs be conducted in tandem. In response to this
new challenge, WHO Consultation of Experts held in
Luxembourg in 2007 [2] laid the groundwork for modi-
fying iodine prophylaxis programs worldwide. In Po-
land, synchronizing these two initiatives is the respon-
sibility of the Program to Eliminate Iodine Deficiency
as well as the National Food and Nutrition Institute.
The work of these two bodies is based on the Position
Paper on Initiatives Aimed at Decreasing Dietary Salt Con-
sumption in Poland, drafted by a panel of national experts
[8]. Recently, the WHO Collaborating Centre at the Cli-
nic of Endocrinology at Jagiellonian University Medi-
cal College has also assumed an important role in syn-
chronizing these two initiatives. The program of the
WHO Collaborating Centre includes, among others,
promoting reduced dietary salt consumption and mo-
difying the iodine prophylaxis program.
Sodium — a major risk factor
for arterial hypertension
Arterial hypertension, found in more than 30% of adult
Poles, is a fundamental risk factor for a variety of car-
Table I. Daily individual salt consumption in selected
European countries (g/day) [1]
Tabela I. Dzienne indywidualne spożycie soli w wybranych
krajach Europy (g/dzień) [1]
Denmark 8.2–8.4
France 7.9–8.4
Belgium 8.3–8.7
Germany 8.2–8.8
Portugal 9.0–11.5
United Kingdom 9.7–11.7
Italy 9.2–10.8
Poland 13.5 g (including 8.8 g table salt) [25]
Sources: WHO 2003, Szponar et al., National Food and Nutrition Institute 2008
Table II. Recommended daily dietary iodine consumption
(mg/person/day) [32]
Tabela II. Rekomendowane dzienne spożycie jodu (mg/osobę/
/dzień) [32]
Preschool-aged children 0–59 months
90
Elementary school — aged 6-12 years
120
Adolescents and adults > 12 years
150
Women, pregnant and nursing 250
Sources: WHO, UNICEF, ICCIDD-22
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diovascular diseases. A further 30% of adult Poles have
normal–high blood pressure, which has also been found
to increase the risk of cardiovascular disease [9–11]. The
relationship between sodium consumption and hyper-
tension has been extensively documented in a variety
of empirical, observational, and intervention studies
[12–14]. The INTERSALT study [15], which covered
a sample population of ten thousand participants, fo-
und that high sodium consumption was directly rela-
ted to higher blood pressure values, which further in-
creased with age. The DASH-Sodium study found that
reduced sodium consumption, as part of a low-sodium
diet, effectively decreased blood pressure. This ultima-
tely led to the development of the “DASH Healthy Diet”:
a diet rich in vegetables, fruits, grains, and fibre, while
being limited in red meat, fats, and desserts. At present,
mean table salt consumption per capita is very high in
Poland, estimated at 15 grams per day. Compared to
other countries participating in the European Project
on Genes in Hypertension (EPOGH), the population of
Kraków was found to have the highest level of sodium
consumption in Poland [11]. Reducing dietary sodium
is one of the main lifestyle recommendations in the tre-
atment of hypertension. The European Society of Hy-
pertension recommends that patients with hyperten-
sion consume no more than 5 grams of salt daily, equ-
ivalent to 2.0 grams (90 mmol) sodium [15]. Carrying
this recommendation over to the general population
may also be worthwhile, possibly leading to an impro-
vement in public health and playing a significant role
in the primary prevention of hypertension and other
cardiovascular diseases.
For several years, Prof. G. MacGregor of the Blood
Pressure Unit at St. George’s University in London (Uni-
ted Kingdom) has been conducting the Consensus Ac-
tion on Salt and Health (CASH). One of the successes
of this program is a noticeable drop in table salt con-
sumption in the United Kingdom. The principles of the
CASH initiative were subsequently applied in the World
Action on Salt and Health (WASH), of which the Polish
Hypertension Society is a member. WASH recommends
including reduced-sodium products in one’s diet [16].
Reducing salt consumption in Poland
in relation to efforts by the European
commission and the WHO
Excessive salt consumption is a risk factor for arterial
hypertension, including its potential complications (e.g.,
stroke, myocardial infarction, cardiac failure), as well
as such noninfectious chronic diseases as atherosclero-
sis, osteoporosis, and certain neoplasms. These consti-
tute the leading causes of death among those aged
60 years and over as well as the second leading causes
of death among those aged 15–59 years. The cost of tre-
ating these patients, especially those with cardiovascu-
lar diseases, is very high. The development of these
health complications is significantly related to the con-
sumption of table salt, which in some countries is very
large. Table salt consumption in Poland currently exce-
eds WHO recommendations (i.e. 5 grams salt/day) by
three-fold. In other European countries it is considera-
bly lower (Table I).
In light of these alarming facts, WHO and EU took
the initiative to reduce mean salt consumption. WHO
recommends developing and incorporating a national
strategy for reducing dietary salt consumption which
reflects, among others, such cultural factors as traditio-
nal cooking habits, main sources of dietary salt, and
population age groups [1].
During the first meeting of the European Commis-
sion’s High Level Group (HLG) on Nutrition and Phy-
sical Activity, held in November 2007, certain countries
proposed initiatives aimed at reducing the salt concen-
tration of certain consumer products. In accordance
with the European Commission’s White Paper, the aim
of these initiatives is to reduce dietary salt consump-
tion at a population level. The results are set to be deli-
vered to the European Commission.
Poland, considering its high levels of salt consump-
tion and high frequency of health complications arising
out of excessive salt consumption, supported these ini-
tiatives by joining this campaign. This lead to the dra-
fting of the Position Paper on Initiatives Aimed at Decre-
asing Dietary Salt Consumption in Poland [8], which was
widely discussed in the general public as well as among
healthcare professionals, the Chief Sanitary Inspector,
scientists and researchers, and food producers. This
document, in supporting the HLG, found that efforts
aimed at reducing salt consumption in Poland should:
— be in agreement with European Commission guide-
lines and constitute part of the National Program to
Prevent Obesity and Non-Infectious Chronic Dise-
ases Through Improving Dietary Habits and Physi-
cal Fitness (POL-HEALTH);
— include simultaneous campaigns meant to educate
consumers, food producers, public health and heal-
thcare professionals, national consumer oversight
bodies, and representatives of the media on how to
reduce the use of salt in one’s diet and recommend
low-sodium consumer products;
— expand dietetic counselling vital to any preventati-
ve endeavours and the treatment of non-infectious
chronic diseases caused by, among others, excessi-
ve salt consumption;
— cooperate with food producers and gastronomic pro-
viders to encourage a gradual change in the recipes
(i.e. reflective of decreased salt usage) of mass-pro-
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duced and other food products considered to be the
main sources of dietary sodium;
— reduce the amount of sodium in meals served by
educational institutions and other gastronomic pro-
viders;
— incorporate healthy eating guidelines into school-
based education, with emphasis on reducing salt
consumption;
— expand the mandate of national consumer oversi-
ght bodies to include quality control of food pro-
ducts, with emphasis on reducing salt consumption;
— continuing legislative efforts aimed at reducing salt
consumption.
It is thought that putting these guidelines — dra-
fted in accordance with European Commission recom-
mendations — into practice will significantly decrease
dietary salt consumption in Poland within a period of
four years. In 2009, Poland will prepare a report deta-
iling what progress has been made in this regard.
Modifying Poland’s iodine prophylaxis
program in response to efforts aimed
at reducing salt consumption
When Poland’s iodine prophylaxis program came to an
end in 1980, a team of paediatricians at the then Acade-
my of Medicine (presently Jagiellonian University Me-
dical College) in Kraków noticed an increase in goiter
among newborns [17]. In 1987, Poland’s Ministry of
Health established a program headed by J. Nauman to
examine the effects of the Chernobyl disaster [18], which
confirmed a high frequency of adult goiter. An epide-
miological study headed by Z. Szybiński in 1992–1993
[19] additionally confirmed a high frequency of goiter
among school-aged children. Following an intervention
by the Polish Endocrinology Association, the iodization
of table salt was reinstated; however, this program was
not initially mandatory. Iodine deficiency places entire
populations at risk of serious health complications. The
synthesis of 4-iodothyronine and thyroxine, hormones
which regulate digestive processes and play a decisive
role in central nervous system (CNS) development, re-
quire a daily dose of dietary iodine. Furthermore, iodi-
ne is one of the strongest known antioxidants and acts
as a protective mechanism in some inflammatory and
neoplastic processes. Serious iodine deficiency in pre-
gnancy may lead to major CNS malformations in the
foetus, as well as cretinism. Such cases, observed in Po-
land between the World Wars, were completely elimi-
nated through iodine prophylaxis interventions. Howe-
ver, even moderate iodine deficiency may lead to ne-
gative health effects such as depressed higher CNS func-
tioning, learning difficulties, problems with memory
and/or cognition, and a significant decrease in IQ
(i.e. the summary measure of these functions). Iodine
deficiency generally leads to an increase in thyroid size
and a greater frequency of different thyroid diseases,
including cancer, and increases the risk of gastric can-
cer. [20, 22, 23].
In 1991, in cooperation with Poland’s Ministry of
Health, the Executive Board of the Polish Endocrinolo-
gy Association convened the Polish Council for Con-
trol of Iodine Deficiency Disorders, headed by Prof. dr
hab. n. med. Z. Szybiński and located at the Chair and
Clinic of Endocrinology at Jagiellonian University in
Kraków (Poland). The Council, modelled on similar
bodies established in various European countries, is made
up of expert endocrists as well as experts in food policy
and the iodization of salt and animal feed.
In light of certain studies which confirmed endemic
levels of goiter in Poland, at the request of the Council,
Poland’s Minister of Health issued an ordinance in 1996
mandating the universal iodization of table salt at le-
vels totalling 30 ± 10 mg KI/1 kg salt. The Council fur-
ther standardized other aspects of Poland’s iodine pro-
phylaxis model to include the iodization of baby for-
mula for non-breastfed infants and iodine supplemen-
tation (0.10–0.15 mg) for women who are pregnant or
breast feeding [24, 25]. Initiatives undertaken by the
Council and coordinated by the Clinic of Endocrinolo-
gy at the University Hospital of Jagiellonian University
Medical College in Kraków (Poland) lead to a dramatic
decrease in the frequency of iodine deficiency along
with its associated negative side effects. Among chil-
dren aged 6–8 years, the frequency of goiter fell to be-
low 5% (i.e., below endemic levels) [7]. In addition,
a decreased frequency of sub-clinical hypothyroidism
was noted among newborns [26, 27]. Such progress led
a conference of WHO experts, as well as the Internatio-
nal Commission for Preventing Iodine Deficiency, to
reclassify Poland as a country with sufficient iodine con-
sumption at a national level [28]. Effective iodine pro-
phylaxis programs also lead to a decrease in the frequ-
ency of medullary thyroid cancer as well as its more
malignant counterpart, follicular thyroid cancer [22].
Decreases in the frequency of gastric cancer have also
been documented as a benefit of effective iodine pro-
phylaxis programs, explained by the protective, antio-
xidant effect of iodine and by the fact that it accumula-
tes in gastric mucosa in distal parts of the stomach [23].
WHO recommendations from Paris (2006) and Lu-
xembourg (2007) instituted the need to restrict dietary
salt consumption, mindful of its role in such diseases as
hypertension and atherosclerosis, to 5 g/day, amoun-
ting to approximately 50% of the current mean con-
sumption. A variety of consumer products serves to play
a potentially important role in making up for probable
decreases in dietary iodine consumption. Among others,
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this includes different types of mineral water containing
standardized concentrations of iodine (0.10–0.20 mg/L)
(Table III). In cooperation with the National Research
Institute of Animal Production, a study was conducted
in 2007–2008 examining iodization of bovine salt licks
[29]. This study found that the iodine concentration in
milk from such cows increased from 30 to 120 ± 10 mg/L
(Table IV), a level comparable to that of other EU coun-
tries which use animal feed supplemented with diffe-
rent nutrients. These two potential sources of iodine
(e.g. mineral water and milk) should ideally be inclu-
ded as part of a balanced diet. Arguably, drinking one
glass of milk per day may be especially beneficial to
children and pregnant women.
Ensuring iodine supplementation at levels totalling
0.10–0.15 mg/day, as recommended by the WHO [30],
in pregnant and breast feeding women constitutes
a unique public health challenge. At present, studies at
the Institute for Mother and Child in Warsaw (Poland)
and the Medical University in Łódź (Poland) have fo-
und that only approximately 50% of pregnant women
receive supplemental doses of iodine [31]. In this re-
gard, general practitioners and obstetricians-gynaeco-
logists play a key role in making sure that pregnant
women receive this supplementary dose of iodine, usu-
ally in tablet form, most often combined with other
minerals and vitamins.
Instituting such changes requires continuous moni-
toring of Poland’s iodine prophylaxis program at a na-
tional level. This monitoring is currently managed by
the Program to Eliminate Iodine Deficiency, financed
by Poland’s Ministry of Health, which monitors TSH
levels in newborns, a very sensitive indicator of pro-
gress in terms of iodine prophylaxis, through routine
screening. ThyroMobile Action is a health promotion pro-
gram aimed at measuring urine iodine concentration
and thyroid size in school-aged children and pregnant
women and, in cooperation with the National Food and
Nutrition Institute, urine sodium and iodine concen-
trations in adults. It also acts as a histopathological re-
gister of thyroid cancer cases. Poland’s iodine prophy-
laxis model also plays a role in protecting the popula-
tion against excess thyroid build-up of isotope 131-I in
case of a disaster similar to that seen in Chernobyl.
Summary
1. The WHO recommends reducing daily table salt (NaCl)
consumption to 5.0 g/day. This amount is generally
considered safe, without heightening the risk for hy-
pertension and its resultant negative health effects
(e.g. atherosclerosis, myocardial infarction, stroke).
2. As part of the National Program to Prevent Obesity
and in line with European Commission recommen-
dations to decrease salt consumption highlighted in
the Position Paper on Initiatives Aimed at Decreasing
Salt Consumption in Poland, developed by the Natio-
nal Food and Nutrition Institute, efforts should be
undertaken to educate consumers, food producers,
healthcare professionals, and media representatives
about work done to gradually change recipes used
in the food industry and catering centres as well as
making lessons in healthy dietary habits an essen-
tial part of mandatory education. Putting these re-
commendations into practice should significantly
reduce mean dietary salt consumption in Poland
within four years. In 2009, Poland will prepare a re-
port highlighting what progress has been made in
these areas.
3. Efforts should be aimed at reducing dietary salt con-
sumption should be coordinated with iodine pro-
phylaxis programs aimed at introducing food pro-
ducts supplemented with iodine, such as milk and
mineral water.
4. Mandatory oversight of reduced salt consumption
programs and iodine prophylaxis programs by sta-
te-run quality control bodies should be carried out.
5. The Program to Eliminate Iodine Deficiency should
be continued, ensuring that Poland’s iodine prophy-
laxis program remains effective.
6. Legislative efforts should be continued aimed at sup-
porting the reduced consumption of table salt in co-
operation with the WHO, and the European Com-
mission.
Acknowledgments
We are thankful to Merck KGaA Darmstadt for their
help in our surveys, especially for providing us with
the “Thyromobil” ambulance.
Table IV. Iodine concentration in cow’s milk [ug/L]
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